United States Animal Drugs Market Report 2017

December 2017 | 103 pages | ID: U84431FF151EN
QYResearch

Abstracts

In this report, the United States Animal Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Animal Drugs in these regions, from 2012 to 2022 (forecast).

United States Animal Drugs market competition by top manufacturers/players, with Animal Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Zoetis
• Boehringer Ingelheim
• Bayer
• Elanco Animal Health
• Ceva
• Dechra
• Merck
• Virbac
• Vetoquinol

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Anti-infective
• Anti-inflammatory
• Parasiticides

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Animal Drugs for each application, including

• Livestock
• Companion

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Animal Drugs Market Report 2017

1 ANIMAL DRUGS OVERVIEW

1.1 Product Overview and Scope of Animal Drugs
1.2 Classification of Animal Drugs by Product Category
  1.2.1 United States Animal Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Animal Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Anti-infective
  1.2.4 Anti-inflammatory
  1.2.5 Parasiticides
1.3 United States Animal Drugs Market by Application/End Users
  1.3.1 United States Animal Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Livestock
  1.3.3 Companion
1.4 United States Animal Drugs Market by Region
  1.4.1 United States Animal Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Animal Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Animal Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Animal Drugs Status and Prospect (2012-2022)
  1.4.5 New England Animal Drugs Status and Prospect (2012-2022)
  1.4.6 The South Animal Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Animal Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Animal Drugs (2012-2022)
  1.5.1 United States Animal Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Animal Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANIMAL DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Animal Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Animal Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Animal Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Animal Drugs Market Competitive Situation and Trends
  2.4.1 United States Animal Drugs Market Concentration Rate
  2.4.2 United States Animal Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Animal Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANIMAL DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Animal Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Animal Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Animal Drugs Price by Region (2012-2017)

4 UNITED STATES ANIMAL DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Animal Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Animal Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Animal Drugs Price by Type (2012-2017)
4.4 United States Animal Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANIMAL DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Animal Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Animal Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANIMAL DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Zoetis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Animal Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Zoetis Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Boehringer Ingelheim
  6.2.2 Animal Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Boehringer Ingelheim Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bayer
  6.3.2 Animal Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Elanco Animal Health
  6.4.2 Animal Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Elanco Animal Health Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Ceva
  6.5.2 Animal Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Ceva Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Dechra
  6.6.2 Animal Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Dechra Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Merck
  6.7.2 Animal Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Merck Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Virbac
  6.8.2 Animal Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Virbac Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Vetoquinol
  6.9.2 Animal Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Vetoquinol Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 ANIMAL DRUGS MANUFACTURING COST ANALYSIS

7.1 Animal Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Animal Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Animal Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Animal Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANIMAL DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Animal Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Animal Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Animal Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Animal Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Animal Drugs
Figure United States Animal Drugs Market Size (K Units) by Type (2012-2022)
Figure United States Animal Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Anti-infective Product Picture
Figure Anti-inflammatory Product Picture
Figure Parasiticides Product Picture
Figure United States Animal Drugs Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Animal Drugs by Application in 2016
Figure Livestock Examples
Table Key Downstream Customer in Livestock
Figure Companion Examples
Table Key Downstream Customer in Companion
Figure United States Animal Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Animal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Animal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Animal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Animal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Animal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Animal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Animal Drugs Sales (K Units) and Growth Rate (2012-2022)
Figure United States Animal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Animal Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Animal Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Animal Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Animal Drugs Sales Share by Players/Suppliers
Figure 2017 United States Animal Drugs Sales Share by Players/Suppliers
Figure United States Animal Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Animal Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Animal Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Animal Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Animal Drugs Revenue Share by Players/Suppliers
Table United States Market Animal Drugs Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Animal Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Animal Drugs Market Share of Top 3 Players/Suppliers
Figure United States Animal Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Animal Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Animal Drugs Product Category
Table United States Animal Drugs Sales (K Units) by Region (2012-2017)
Table United States Animal Drugs Sales Share by Region (2012-2017)
Figure United States Animal Drugs Sales Share by Region (2012-2017)
Figure United States Animal Drugs Sales Market Share by Region in 2016
Table United States Animal Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Animal Drugs Revenue Share by Region (2012-2017)
Figure United States Animal Drugs Revenue Market Share by Region (2012-2017)
Figure United States Animal Drugs Revenue Market Share by Region in 2016
Table United States Animal Drugs Price (USD/Unit) by Region (2012-2017)
Table United States Animal Drugs Sales (K Units) by Type (2012-2017)
Table United States Animal Drugs Sales Share by Type (2012-2017)
Figure United States Animal Drugs Sales Share by Type (2012-2017)
Figure United States Animal Drugs Sales Market Share by Type in 2016
Table United States Animal Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Animal Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Animal Drugs by Type (2012-2017)
Figure Revenue Market Share of Animal Drugs by Type in 2016
Table United States Animal Drugs Price (USD/Unit) by Types (2012-2017)
Figure United States Animal Drugs Sales Growth Rate by Type (2012-2017)
Table United States Animal Drugs Sales (K Units) by Application (2012-2017)
Table United States Animal Drugs Sales Market Share by Application (2012-2017)
Figure United States Animal Drugs Sales Market Share by Application (2012-2017)
Figure United States Animal Drugs Sales Market Share by Application in 2016
Table United States Animal Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Animal Drugs Sales Growth Rate by Application (2012-2017)
Table Zoetis Basic Information List
Table Zoetis Animal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Zoetis Animal Drugs Sales Growth Rate (2012-2017)
Figure Zoetis Animal Drugs Sales Market Share in United States (2012-2017)
Figure Zoetis Animal Drugs Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Animal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Animal Drugs Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Animal Drugs Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Animal Drugs Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Animal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Animal Drugs Sales Growth Rate (2012-2017)
Figure Bayer Animal Drugs Sales Market Share in United States (2012-2017)
Figure Bayer Animal Drugs Revenue Market Share in United States (2012-2017)
Table Elanco Animal Health Basic Information List
Table Elanco Animal Health Animal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Elanco Animal Health Animal Drugs Sales Growth Rate (2012-2017)
Figure Elanco Animal Health Animal Drugs Sales Market Share in United States (2012-2017)
Figure Elanco Animal Health Animal Drugs Revenue Market Share in United States (2012-2017)
Table Ceva Basic Information List
Table Ceva Animal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ceva Animal Drugs Sales Growth Rate (2012-2017)
Figure Ceva Animal Drugs Sales Market Share in United States (2012-2017)
Figure Ceva Animal Drugs Revenue Market Share in United States (2012-2017)
Table Dechra Basic Information List
Table Dechra Animal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dechra Animal Drugs Sales Growth Rate (2012-2017)
Figure Dechra Animal Drugs Sales Market Share in United States (2012-2017)
Figure Dechra Animal Drugs Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Animal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Animal Drugs Sales Growth Rate (2012-2017)
Figure Merck Animal Drugs Sales Market Share in United States (2012-2017)
Figure Merck Animal Drugs Revenue Market Share in United States (2012-2017)
Table Virbac Basic Information List
Table Virbac Animal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Virbac Animal Drugs Sales Growth Rate (2012-2017)
Figure Virbac Animal Drugs Sales Market Share in United States (2012-2017)
Figure Virbac Animal Drugs Revenue Market Share in United States (2012-2017)
Table Vetoquinol Basic Information List
Table Vetoquinol Animal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Vetoquinol Animal Drugs Sales Growth Rate (2012-2017)
Figure Vetoquinol Animal Drugs Sales Market Share in United States (2012-2017)
Figure Vetoquinol Animal Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Animal Drugs
Figure Manufacturing Process Analysis of Animal Drugs
Figure Animal Drugs Industrial Chain Analysis
Table Raw Materials Sources of Animal Drugs Major Players/Suppliers in 2016
Table Major Buyers of Animal Drugs
Table Distributors/Traders List
Figure United States Animal Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Animal Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Animal Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Animal Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Animal Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Animal Drugs Sales Volume (K Units) Forecast by Type in 2022
Table United States Animal Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Animal Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Animal Drugs Sales Volume (K Units) Forecast by Application in 2022
Table United States Animal Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Animal Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Animal Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Animal Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources